IL99652A - Sertindole prodrugs, their preparation and pharmaceutical compositions containing them - Google Patents
Sertindole prodrugs, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL99652A IL99652A IL99652A IL9965291A IL99652A IL 99652 A IL99652 A IL 99652A IL 99652 A IL99652 A IL 99652A IL 9965291 A IL9965291 A IL 9965291A IL 99652 A IL99652 A IL 99652A
- Authority
- IL
- Israel
- Prior art keywords
- group
- sertindole
- nr2r3
- iii
- optionally substituted
- Prior art date
Links
- GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000652 sertindole Drugs 0.000 title abstract 3
- 239000000651 prodrug Substances 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK238190A DK238190D0 (da) | 1990-10-03 | 1990-10-03 | Depotderivater |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL99652A0 IL99652A0 (en) | 1992-08-18 |
| IL99652A true IL99652A (en) | 1997-04-15 |
Family
ID=8111993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL99652A IL99652A (en) | 1990-10-03 | 1991-10-04 | Sertindole prodrugs, their preparation and pharmaceutical compositions containing them |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5428036A (pt) |
| EP (1) | EP0592433B1 (pt) |
| JP (1) | JP3100980B2 (pt) |
| KR (1) | KR100212430B1 (pt) |
| AT (1) | ATE175964T1 (pt) |
| AU (1) | AU652783B2 (pt) |
| CA (1) | CA2093433C (pt) |
| DE (1) | DE69130803T2 (pt) |
| DK (2) | DK238190D0 (pt) |
| ES (1) | ES2125870T3 (pt) |
| FI (1) | FI102679B1 (pt) |
| GR (1) | GR3029399T3 (pt) |
| IE (1) | IE913384A1 (pt) |
| IL (1) | IL99652A (pt) |
| NO (1) | NO301475B1 (pt) |
| NZ (1) | NZ240051A (pt) |
| PH (1) | PH30129A (pt) |
| PT (1) | PT99142B (pt) |
| WO (1) | WO1992006089A1 (pt) |
| ZA (1) | ZA917881B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK206591D0 (da) * | 1991-12-23 | 1991-12-23 | Lundbeck & Co As H | Behandling af psykoser |
| JPH0625964U (ja) * | 1992-05-25 | 1994-04-08 | ミクロン機器株式会社 | 通信機能付きコインカウンタ及び有料装置 |
| US6489341B1 (en) * | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| US8552054B2 (en) | 2001-03-23 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Fatty amine drug conjugates |
| JP4634694B2 (ja) | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
| US20100168197A1 (en) * | 2007-02-28 | 2010-07-01 | Naresh Kumar | Muscarinic receptor antagonists |
| CA2937222C (en) * | 2009-06-25 | 2019-06-04 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds |
| ES3031438T3 (en) | 2009-06-25 | 2025-07-08 | Alkermes Pharma Ireland Ltd | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| WO2011163594A2 (en) * | 2010-06-24 | 2011-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
| US4038305A (en) * | 1972-03-20 | 1977-07-26 | Aktieselskabet Grindstedvaerket | Cyclopentenone derivatives |
| GB1469108A (en) * | 1973-06-25 | 1977-03-30 | Kefalas As | Thiaxanthene derivative |
| JPS568318A (en) * | 1979-06-28 | 1981-01-28 | Janssen Pharmaceutica Nv | Non oral long acting composition of haloperidol and bromperidol derivative |
| IT1199116B (it) * | 1984-07-03 | 1988-12-30 | Fidia Farmaceutici | Derivati di gangliosidi |
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| GB8621892D0 (en) * | 1986-09-11 | 1986-10-15 | Lundbeck & Co As H | Organic compound |
| GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
| DE3921886A1 (de) * | 1989-07-04 | 1991-01-17 | Wolfgang Mohr | Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut |
-
1990
- 1990-10-03 DK DK238190A patent/DK238190D0/da not_active Application Discontinuation
-
1991
- 1991-09-26 IE IE338491A patent/IE913384A1/en not_active IP Right Cessation
- 1991-09-27 WO PCT/DK1991/000291 patent/WO1992006089A1/en not_active Ceased
- 1991-09-27 DE DE69130803T patent/DE69130803T2/de not_active Expired - Fee Related
- 1991-09-27 EP EP91919394A patent/EP0592433B1/en not_active Expired - Lifetime
- 1991-09-27 AT AT91919394T patent/ATE175964T1/de not_active IP Right Cessation
- 1991-09-27 DK DK91919394T patent/DK0592433T3/da active
- 1991-09-27 JP JP03516372A patent/JP3100980B2/ja not_active Expired - Fee Related
- 1991-09-27 KR KR1019930701041A patent/KR100212430B1/ko not_active Expired - Fee Related
- 1991-09-27 CA CA002093433A patent/CA2093433C/en not_active Expired - Fee Related
- 1991-09-27 ES ES91919394T patent/ES2125870T3/es not_active Expired - Lifetime
- 1991-09-27 AU AU87104/91A patent/AU652783B2/en not_active Ceased
- 1991-10-01 NZ NZ240051A patent/NZ240051A/xx not_active IP Right Cessation
- 1991-10-01 PH PH43225A patent/PH30129A/en unknown
- 1991-10-02 ZA ZA917881A patent/ZA917881B/xx unknown
- 1991-10-02 PT PT99142A patent/PT99142B/pt not_active IP Right Cessation
- 1991-10-04 IL IL99652A patent/IL99652A/xx not_active IP Right Cessation
-
1993
- 1993-03-30 US US08/039,228 patent/US5428036A/en not_active Expired - Lifetime
- 1993-03-31 NO NO931219A patent/NO301475B1/no unknown
- 1993-04-01 FI FI931472A patent/FI102679B1/fi not_active IP Right Cessation
-
1999
- 1999-02-12 GR GR990400483T patent/GR3029399T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ240051A (en) | 1993-05-26 |
| DK0592433T3 (da) | 1999-09-13 |
| US5428036A (en) | 1995-06-27 |
| KR100212430B1 (ko) | 1999-08-02 |
| DK238190D0 (da) | 1990-10-03 |
| KR930702335A (ko) | 1993-09-08 |
| EP0592433B1 (en) | 1999-01-20 |
| HK1009273A1 (en) | 1999-05-28 |
| GR3029399T3 (en) | 1999-05-28 |
| NO931219L (no) | 1993-04-01 |
| ATE175964T1 (de) | 1999-02-15 |
| AU8710491A (en) | 1992-04-28 |
| CA2093433C (en) | 2000-11-21 |
| FI102679B (fi) | 1999-01-29 |
| CA2093433A1 (en) | 1992-04-04 |
| AU652783B2 (en) | 1994-09-08 |
| FI931472A7 (fi) | 1993-04-01 |
| IL99652A0 (en) | 1992-08-18 |
| FI931472A0 (fi) | 1993-04-01 |
| DE69130803T2 (de) | 1999-08-19 |
| FI102679B1 (fi) | 1999-01-29 |
| PH30129A (en) | 1997-01-21 |
| PT99142A (pt) | 1994-02-28 |
| IE913384A1 (en) | 1992-04-08 |
| JP3100980B2 (ja) | 2000-10-23 |
| ES2125870T3 (es) | 1999-03-16 |
| DE69130803D1 (de) | 1999-03-04 |
| PT99142B (pt) | 1999-04-30 |
| ZA917881B (en) | 1992-07-29 |
| JPH06501939A (ja) | 1994-03-03 |
| NO301475B1 (no) | 1997-11-03 |
| WO1992006089A1 (en) | 1992-04-16 |
| NO931219D0 (no) | 1993-03-31 |
| EP0592433A1 (en) | 1994-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU649849B2 (en) | New vanadium complexes, process for preparing them and pharmaceutical compositions containing them | |
| YU48855B (sh) | Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksi-triptamina i postupak njihovog dobijanja | |
| SE9203318D0 (sv) | Novel 3,3-diphenylpropylamines, their use and preparation | |
| ATE33838T1 (de) | Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| IL103944A (en) | Piperazine derivatives, their preparation and pharmaceutical compositions containing them | |
| EP0487502A3 (en) | Pharmaceutically active aryl-substituted amine derivatives | |
| SE9703377D0 (sv) | New compounds | |
| ES8200011A1 (es) | Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. | |
| GB1120463A (en) | Derivatives of 1,3-diazafluoranthene-1-oxide | |
| MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
| PH30129A (en) | Sertindole prodrug compositions and use | |
| DE3170937D1 (en) | 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them | |
| ATE215075T1 (de) | Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend | |
| IL115085A (en) | Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| ES8602756A1 (es) | Procedimiento para preparar nuevos derivados de 2-(1-imida- zolil)-etanol | |
| ES8407318A1 (es) | Procedimiento de preparacion de derivados de piperacina. | |
| FR2683221B1 (fr) | Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique. | |
| SE8000699L (sv) | Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem | |
| GB1193534A (en) | Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same | |
| ATE23150T1 (de) | Aminoethoxybenzylalkohol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| HU894471D0 (en) | Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them | |
| SE317382B (pt) | ||
| ES304710A1 (es) | Procedimiento para la preparaciën de 1,3,5-triacinas | |
| ES304772A1 (es) | PROCEDIMIENTO PARA LA PREPARACION DE 10, 11-DIHIDRO-11-OXO-5H-DIBENZO (B, E) (1, 4) DIAZEPINAS BáSICAMENTE SUSTITUIDAS | |
| GB1219847A (en) | Novel 3-amino-4-oxo-1h-4,5-dihydro-1,2,5-benzotriazepines, processes for their preparation, and compositions incorporating them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |